BMS-182123, a fungal metabolite that inhibits the production of TNF-α by macrophages and monocytes

Journal of Antibiotics

Volumn 49, Issue 3, 1996, Pages 234-240

  Warr, Glenn A ^a   Veitch, Judith A ^a   Walsh, Ann W ^a   Hesler, Grace A ^a   Pirnik, Dolores M ^a   Leet, John E ^a   Lin, Pin Fang M ^a   Medina, Ivetta A ^a   Mcbrien, Kimberly D ^a   Forenza, Salvatore ^a   Clark, Junius M ^a   Lam, Kin Sing ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BMS 182123; ENDOTOXIN; MESSENGER RNA; POLACRILIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL SECRETION; CONTROLLED STUDY; DRUG ISOLATION; DRUG MANUFACTURE; DRUG POTENCY; DRUG PURIFICATION; FERMENTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PENICILLIUM CHRYSOGENUM; PRIORITY JOURNAL; TAXONOMY;

EID: 15844402152     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.49.234     Document Type: Article

References (27)

1. MANNEL, D. N.; R. N. MOORE & S. E. MERGENHAGEN: Macrophages as a source of tumoricidal activity (tumor necrotizing factor). Infect. Immun. 30: 523-530, 1980
2. NISSEN-MEYER, J. & J. HAMMERSTROM: Physicochemical characterization of cytostatic factors released from human monocytes. Infect. Immun. 38: 67-72, 1982
3. LASFARGUES, A. & R. CHARBY: Endotoxin-induced tumor necrosis factor (TNF): selective triggering of TNF and interleukin-1 production by distinct glucosamine-derived lipids. Cell. Immunol. 115: 165-178, 1986
4. HENTER, I.-T.; O. SODOR & U. ANDERSON: Identification of individual tumor necrosis factor/cachetin-producing cells after lipopolysaccharide induction. Eur. J. Immunol. 18: 983-988, 1988
5. GIROIR, B. P. & B. BEULTER: Effect of amrinone on tumor necrosis factor production in endotoxic shock. Cir. Shock 36: 200-207, 1992
6. TRACEY, K. J.; Y. FONG, D. G. HESSE, K. R. MANOGUE, A. T. LEE, G. C. KUO, S. F. LOWRY & A. CERAMI: Anti-cachectin/TNF monoclonal antibiodies prevent septic shock during lethal bacteraemia. Nature 330: 662-664, 1987
7. DAMAS, P.; A. REUTER, P. GYSEN, J. DEMONTY, M. LAMY & P. FRANCHIMONT: Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit. Care Med. 17: 975-978, 1989
8. BEUTLER, B.; I. W. MILSARK & A. CERAMI: Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229: 869-871, 1985
9. α). Cir. Shock 30: 279-292, 1990
10. MORRISON, D. C.; C. A. DINARELLO, R. S. MUNFORD, C. NATANSON, R. DANNER, M. POLLACK, J. J. SPITZER, R. J. ULEVITCH, S. N. VOGEL & E. MCSWEEGAN: Current status of bacterial endotoxins. ASM News 60: 479-484, 1994
11. GLAUSEN, M. P.; D. HEUMANN, J. D. BAUMGARTNER & J. COHEN: Pathogenesis and potential strategies for prevention and treatment of septic shock: An update. Clin. Infect. Dis. 18 (Suppl. 2): 205-216, 1994
12. PENNINGTON, J.: TNF: Therapeutic target in patients with sepsis. ASM News 58: 479-482, 1992
13. SMITH, E. F. III; M. J. SLIVJAK, J. O. BARTUS & K. M. ESSER: SK & F 86002 inhibits tumor necrosis factor formation and improves survival in endotoxemic rats. J. Cardiovasc. Pharmacol. 18: 721-728, 1991
14. ECONOMOU, J. S.; K. RHOADES, R. ESSNER, W. H. MCBRIDE, J. C. GASSON & D. L. MORTON: Genetic analysis of human tumor necrosis factor α/cachectin promoter region in a macrophage cell line. J. Exp. Med. 170: 321-326, 1989
15. LYNCH, M. J.; L. PELOSI, J. M. CARBONI, J. MERWIN, K. COLEMAN, R. R. C. WANG, P. F. M. LIN, D. L. HENRY & M. G. BRATTAIN: Transforming growth factor-β1 induces transforming growth factor-α promoter activity and transforming growth factor-α secretion in the human colon adenocarcinoma cell line FET. Cancer Res. 53: 4041-4047, 1993
16. KIENER, P. A.; F. MAREK, G. RODGERS, P. F. LIN, G. WARR & J. DESIDERIO: Induction of tumor necrosis factor, IFN-γ, an acute lethality in mice by toxic and non-toxic forms of lipid A. J. Immunol. 141: 870-874, 1988
17. GROVE, R. I.; N. J. ALLEGRETTO, P. A. KIENER & G. A. WARR: Lipopolysaccharide (LPS) alters phosphatidylcholine metabolism in elicited peritoneal macrophages. J. Leukocyte Biol. 48: 38-42, 1990
18. CHOMCZYNSKI, P. & N. SACCHI: Single-step method of RNA isolation by acid guanidium thiocyantate-phenolchloroform extraction. Anal. Biochem. 162: 156-159, 1987
19. HENDERSON, G. S.; J. T. CONARY, J. M. DAVIDSON, S. J. STEWART, F. S. HOUSE & T. L. MCCURLEY: A reliable method for northern blot analysis using synthetic oligonucleotide probes. BioTechniques 10: 190-197, 1991
20. RAPER, K. & C. THOM: In Mamual of the Penicillia, Williams and Wilkins Co., 1949
21. RAMIREZ, C.: In Manual and Atlas of the Penicillia, Elsevier Biomedical, 1982
22. MARSHALL, V. P.; S. J. MCWETHY, J. M. SIROTTI & J. I. CIAIDELLA: The effect of neutral resins on the fermentation production of rubradirin. J. Ind. Microbiol. 5: 283-288, 1990
23. 1 by Actinomadura verrucosospora. J. Ind. Microbiol. 12: 99-102, 1993
24. 1α: Fermentation, isolation, biological properties. J. Antibiotics 47: 23-31, 1994
25. JARVIS, B. B.; C. A. ARMSTRONG & M. ZENG: Use of resins for trichothecene production in liquid cultures. J. Antibiotics 43: 1502-1504, 1990
26. ANDRADE, R.; W. A. AYER & P. P. MEBE: The metabolites of Trichoderma longibrachiatum. Part I. Isolation of the metabolites and the structure of trichodimerol. Can. J. Chem. 70: 2526-2535, 1992
27. GAO, Q.; J. E. LEET, S. T. THOMAS, J. A. MATSON & D. P. BRANCROFT: Crystal structure of trichodimerol. J. Nat. Prod. 58: 1817-1821, 1995